Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain

Choroidal neovascularization (CNV) is a key pathological feature of several leading causes of vision loss including neovascular age-related macular degeneration. Here, we show that a calreticulin anti-angiogenic domain (CAD)-like peptide 27, CAD27, inhibited in vitro angiogenic activities, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Bee, Youn-Shen, Ma, Yi-Ling, Chen, Jinying, Tsai, Pei-Jhen, Sheu, Shwu-Jiuan, Lin, Hsiu-Chen, Huang, Hu, Liu, Guei-Sheung, Tai, Ming-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213176/
https://www.ncbi.nlm.nih.gov/pubmed/30274378
http://dx.doi.org/10.3390/ijms19102993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213176/
https://www.ncbi.nlm.nih.gov/pubmed/30274378
http://dx.doi.org/10.3390/ijms19102993

Ejemplares similares